The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Clinical translation of nanomedicines: Challenges, opportunities, and keys
Abstract
Despite the massive interest and recent developments in the field of nanomedicine, only a limited number of formulations have found their way to the clinics. This shortcoming reveals the challenges facing the clinical translation of this technology. In the current article, we summarize and evaluate the status, market situation, and clinical profiles of the reported nanomedicines, the shortcomings limiting their clinical translation, as well as some approaches designed to break through this barrier. Moreover, some emerging technologies that have the potential to compete with nanomedicines are highlighted. Lastly, we identify the key factors that should be considered in nanomedicine-related research to be clinically-translatable. These can be classified into five areas: rational design during the research and development stage, the recruitment of representative preclinical models, careful design of clinical trials, development of specific and uniform regulatory protocols, and calls for non-classic sponsorship. This new field of endeavor was firmly established during the last two decades and more in-depth progress is expected in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Chaotic Mixer for Microchannels
Stroock, A. D., Dertinger, S. K. W., Ajdari, A., Mezić, I., Stone, H. A., & Whitesides, G. M. (2002) · Science · doi:10.1126/science.1066238 · Cited by 3,435
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Nanoparticles in the clinic: an update
Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766
Freeze-drying of nanoparticles: Formulation, process and storage considerations
ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Zielińska, A., Carreiró, F., Oliveira, A. M., Neves, A., Pires, B., Venkatesh, D. N., Durazzo, A., Lucarini, M., Eder, P., Silva, A. M., et al. (2020) · Molecules · doi:10.3390/molecules25163731 · Cited by 1,560
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Stimuli-responsive polymers and their applications
Wei, M., Gao, Y., Li, X., & Serpe, M. J. (2017) · Polymer Chemistry · doi:10.1039/c6py01585a · Cited by 1,298
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Fogel, D. B. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.08.001 · Cited by 1,035
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Polymer–drug conjugate therapeutics: advances, insights and prospects
Ekladious, I., Colson, Y. L., & Grinstaff, M. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0005-0 · Cited by 855
Nanomedicine: Principles, Properties, and Regulatory Issues
Soares, S., Sousa, J., Pais, A., & Vitorino, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00360 · Cited by 790
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 688
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685
Toxicity of metal and metal oxide nanoparticles: a review
Sengul, A. B., & Asmatulu, E. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01033-6 · Cited by 681
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery
Opatha, S. A. T., Titapiwatanakun, V., & Chutoprapat, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090855 · Cited by 537
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496
Inorganic and metal nanoparticles and their antimicrobial activity in food packaging applications
Hoseinnejad, M., Jafari, S. M., & Katouzian, I. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1332001 · Cited by 487
Nanomedicine scale-up technologies: feasibilities and challenges
Paliwal, R., Babu, R. J., & Palakurthi, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0177-9 · Cited by 466
Toxicity of gold nanoparticles (AuNPs): A review
Sani, A., Cao, C., & Cui, D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100991 · Cited by 454
Applications of Colloidal Inorganic Nanoparticles: From Medicine to Energy
Lohse, S. E., & Murphy, C. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307589n · Cited by 430
Delivering the power of nanomedicine to patients today
Germain, M., Caputo, F., Metcalfe, S., Tosi, G., Spring, K., Åslund, A. K. O., Pottier, A., Schiffelers, R., Ceccaldi, A., & Schmid, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.007 · Cited by 405
Challenges in nanomedicine clinical translation
Metselaar, J. M., & Lammers, T. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00740-5 · Cited by 396
Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems
Leung, A. K. K., Tam, Y. Y. C., Chen, S., Hafez, I. M., & Cullis, P. R. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b02891 · Cited by 359
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620874114 · Cited by 335
Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 319
Self-citationInorganic nanoparticles for biomedicine: where materials scientists meet medical research
Giner-Casares, J. J., Henriksen-Lacey, M., Coronado-Puchau, M., & Liz-Marzán, L. M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.07.004 · Cited by 317
Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature
Zhang, S., Wan, Z., & Kamm, R. D. (2021) · Lab on a Chip · doi:10.1039/d0lc01186j · Cited by 316
Systemic Review of Biodegradable Nanomaterials in Nanomedicine
Su, S., & Kang, P. M. (2020) · Nanomaterials · doi:10.3390/nano10040656 · Cited by 312
Blood-Brain Delivery Methods Using Nanotechnology
Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040269 · Cited by 305
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
Tebas, P., Yang, S., Boyer, J. D., Reuschel, E. L., Patel, A., Christensen-Quick, A., Andrade, V. M., Morrow, M. P., Kraynyak, K., Agnes, J., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100689 · Cited by 270
Kimura, N., Maeki, M., Sato, Y., Note, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2018) · ACS Omega · doi:10.1021/acsomega.8b00341 · Cited by 227
Self-citationA Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
Ramishetti, S., Hazan‐Halevy, I., Palakuri, R., Chatterjee, S., Naidu Gonna, S., Dammes, N., Freilich, I., Kolik Shmuel, L., Danino, D., & Peer, D. (2020) · Advanced Materials · doi:10.1002/adma.201906128 · Cited by 211
Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.005 · Cited by 209
Roadmap and strategy for overcoming infusion reactions to nanomedicines
Szebeni, J., Simberg, D., González-Fernández, Á., Barenholz, Y., & Dobrovolskaia, M. A. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0273-1 · Cited by 205
Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187962 · Cited by 194
Self-citationOpsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines
Papini, E., Tavano, R., & Mancin, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.567365 · Cited by 192
Click Chemistry as a Tool for Cell Engineering and Drug Delivery
Takayama, Y., Kusamori, K., & Nishikawa, M. (2019) · Molecules · doi:10.3390/molecules24010172 · Cited by 187
Zhou, K., Nguyen, L. H., Miller, J. B., Yan, Y., Kos, P., Xiong, H., Li, L., Hao, J., Minnig, J. T., Zhu, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520756113 · Cited by 183
Sato, Y., Hashiba, K., Sasaki, K., Maeki, M., Tokeshi, M., & Harashima, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.001 · Cited by 179
Self-citationNiosomal drug delivery for transdermal targeting: recent advances
Muzzalupo, R., & Tavano, L. (2015) · Research and Reports in Transdermal Drug Delivery · doi:10.2147/rrtd.s64773 · Cited by 170
Chang, B., Chen, D., Wang, Y., Chen, Y., Jiao, Y., Sha, X., & Yang, W. (2013) · Chemistry of Materials · doi:10.1021/cm3037197 · Cited by 170
Cazzamalli, S., Corso, A. D., Widmayer, F., & Neri, D. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13361 · Cited by 168
Wang, L. L., Janes, M. E., Kumbhojkar, N., Kapate, N., Clegg, J. R., Prakash, S., Heavey, M. K., Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10214 · Cited by 162
Artificial intelligence in nanomedicine
Ho, D., Wang, P., & Kee, T. W. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00233a · Cited by 158
The beginning of the end of the nanomedicine hype
Park, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.044 · Cited by 158
Pharmaceutical Stability Aspects of Nanomedicines
Muthu, M. S., & Feng, S. (2009) · Nanomedicine · doi:10.2217/nnm.09.75 · Cited by 146
Long Covid: where we stand and challenges ahead
Mantovani, A., Morrone, M. C., Patrono, C., Santoro, M., Schiaffino, S., Remuzzi, G., Bussolati, G., On behalf of the Covid-19 Commission of the Accademia Nazionale dei Lincei, Cappuccinelli, P., Fitzgerald, G., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01052-6 · Cited by 141
Jones, D. E., Ghandehari, H., & Facelli, J. C. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.04.025 · Cited by 134
Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery
Malachowski, T., & Hassel, A. (2020) · Engineered Regeneration · doi:10.1016/j.engreg.2020.06.001 · Cited by 129
Younis, M. A., Khalil, I. A., Elewa, Y. H. A., Kon, Y., & Harashima, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.021 · Cited by 126
Self-citationKhan, O. F., Kowalski, P. S., Doloff, J. C., Tsosie, J. K., Bakthavatchalu, V., Winn, C. B., Haupt, J. L., Jamiel, M., Langer, R., & Anderson, D. G. (2018) · Science Advances · doi:10.1126/sciadv.aar8409 · Cited by 124
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Cost–Effectiveness of Nanomedicine: Estimating the Real Size of Nano-Costs
Bosetti, R., & Jones, S. L. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0130 · Cited by 117
Future Perspectives of Therapeutic Monoclonal Antibodies
Tsumoto, K., Isozaki, Y., Yagami, H., & Tomita, M. (2019) · Immunotherapy · doi:10.2217/imt-2018-0130 · Cited by 115
Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides
Ochoa, S., & Milam, V. T. (2020) · Molecules · doi:10.3390/molecules25204659 · Cited by 113
Dong, Y., Wu, X., Chen, X., Zhou, P., Xu, F., & Liang, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111236 · Cited by 113
Patient‑derived xenograft mouse models: A high fidelity tool for individualized medicine (Review)
Xu, C., Li, X., Liu, P., Li, M., & Luo, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9583 · Cited by 112
History and Possible Uses of Nanomedicine Based on Nanoparticles and Nanotechnological Progress
Krukemeyer, M. G., Krenn, V., & Huebner, F. (2015) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000336 · Cited by 111
Polymeric drugs: Advances in the development of pharmacologically active polymers
Li, J., Yu, F., Chen, Y., & Oupický, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.043 · Cited by 108
AmBisome targeting to fungal infections.
Adler‐Moore, J. (1994) · PubMed · Cited by 107
In silico modelling of cancer nanomedicine, across scales and transport barriers
Stillman, N., Kovačević, M., Balaž, I., & Hauert, S. (2020) · npj Computational Materials · doi:10.1038/s41524-020-00366-8 · Cited by 100
Nanomedicine, an emerging therapeutic strategy for oral cancer therapy
Marcazzan, S., Varoni, E. M., Blanco, E., Lodi, G., & Mauro Ferrari, B. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.11.014 · Cited by 99
Liang, L., Lin, S., Dai, W., Lu, J., Yang, T., Xiang, Y., Zhang, Y., Li, R., & Zhang, Q. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.020 · Cited by 97
Inorganic Nanoparticles for Image-Guided Therapy
Yoon, H. Y., Jeon, S., You, D. G., Park, J. H., Kwon, I. C., Koo, H., & Kim, K. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00512 · Cited by 92
Song, Y., Shi, Y., Zhang, L., Hu, H., Zhang, C., Yin, M., Chu, L., Yan, X., Zhao, M., Zhang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00809 · Cited by 86
Elwakil, M. M. A., Khalil, I. A., Elewa, Y. H. A., Kusumoto, K., Sato, Y., Shobaki, N., Kon, Y., & Harashima, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807677 · Cited by 80
Self-citation3D Printing in Development of Nanomedicines
Jain, K., Shukla, R., Yadav, A. K., Ujjwal, R. R., & Flora, S. J. S. (2021) · Nanomaterials · doi:10.3390/nano11020420 · Cited by 80
The Future of Pharmaceutical Product Development and Research
(2020) · Elsevier eBooks · doi:10.1016/c2017-0-01075-3 · Cited by 79
Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma
Sato, K., Zhang, W., Safarikia, S., Isidan, A., Chen, A. M., Li, P., Francis, H., Kennedy, L. L., Baiocchi, L., Alvaro, D., et al. (2020) · Hepatology · doi:10.1002/hep.31653 · Cited by 75
Strategies on the nuclear-targeted delivery of genes
Yao, J., Fan, Y., Li, Y., & Huang, L. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.830310 · Cited by 74
Hashiba, A., Toyooka, M., Sato, Y., Maeki, M., Tokeshi, M., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.031 · Cited by 69
Self-citationYounis, M. A., Khalil, I. A., Elwakil, M. M. A., & Harashima, H. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00738 · Cited by 68
Self-citationLipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids
Khalil, I. A., Younis, M. A., Kimura, S., & Harashima, H. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00743 · Cited by 68
Self-citationProject, Design, and Use of a Pilot Plant for Nanocapsule Production
Colombo, A. P., Briançon, S., Liéto, J., et al. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100108369 · Cited by 67
Zhou, S., Deng, H., Zhang, Y., Wu, P., He, B., Dai, W., Zhang, H., Zhang, Q., Zhao, R., & Wang, X. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00971 · Cited by 67
Dormont, F., Rouquette, M., Mahatsekake, C., Gobeaux, F., Peramo, A., Brusini, R., Calet, S., Testard, F., Lepêtre‐Mouelhi, S., Desmaële, D., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.040 · Cited by 66
Zhao, Y., Qu, B., Wu, X., Li, X., Liu, Q., Jin, X., Guo, L., Hai, L., & Wu, Y. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.072 · Cited by 64
Do not keep it simple: recent advances in the generation of complex organoids
Wörsdörfer, P., Ito, T., Asahina, I., Sumita, Y., & Ergün, S. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02198-8 · Cited by 63
Engineered Nanoparticles with Antimicrobial Property
Reshma, V. G., Syama, S., Sruthi, S., Cherian, R. S., Remya, N. S., & Mohanan, P. V. (2017) · Current Drug Metabolism · doi:10.2174/1389200218666170925122201 · Cited by 60
Dikpati, A. A., Mohammadi, F., Greffard, K., Quéant, C., Arnaud, P., Bastiat, G., Rudkowska, I., & Bertrand, N. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02877-x · Cited by 58
Lee, F. A. S., Zee, B. C.-Y., Cheung, F. Y., Kwong, P., Chiang, C., Leung, K. C., Siu, S. W. K., Lee, C., Lai, M., Kwok, C., et al. (2014) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000099 · Cited by 53
Antibacterial nanotruffles for treatment of intracellular bacterial infection
Elnaggar, M. G., Jiang, K., Eldesouky, H. E., Pei, Y., Park, J., Yuk, S. A., Meng, F., Dieterly, A. M., Mohammad, H. T., Hegazy, Y. A., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120344 · Cited by 53
Self-citationUtilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer
Julien, D. C., Behnke, S., Wang, G., Murdoch, G. K., & Hill, R. A. (2011) · mAbs · doi:10.4161/mabs.3.5.16089 · Cited by 44
Scalable Manufacturing Processes for Solid Lipid Nanoparticles
Anderluzzi, G., Lou, G., Su, Y., & Perrie, Y. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190925112942 · Cited by 39
Sakurai, Y., Mizumura, W., Ito, K., Iwasaki, K., Katoh, T., Goto, Y., Suga, H., & Harashima, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00087 · Cited by 39
Self-citationSridhar, S. S., Blais, N., Tran, B., Reaume, M. N., North, S. A., Stockler, M. R., Chi, K. N., Fleshner, N. E., Liu, G., Robinson, J. W., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3927 · Cited by 38
Younis, M. A., Khalil, I. A., & Harashima, H. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000087 · Cited by 26
Self-citationNanomedicine: From where are we coming and where are we going?
Couvreur, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.020 · Cited by 24
Atia, N. N., Tawfeek, H. M., Rageh, A. H., El‐Zahry, M. R., Abdelfattah, A. M., & Younis, M. A. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.02.001 · Cited by 22
Self-citationIssues, challenges, and opportunities in model-based drug development for monoclonal antibodies
Hu, L., & Hansen, R. J. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23504 · Cited by 17
Wang, M., Huang, M., Wang, J., Ye, M., Deng, Y., Li, H., Qian, W., Zhu, B., Zhang, Y., & Gong, R. (2016) · Journal of Nanomaterials · doi:10.1155/2016/5752921 · Cited by 13
Scale-up considerations for monoclonal antibody production process: an oxygen transfer flux approach
Giménez, L., Simonet, C., & Malphettes, L. (2013) · BMC Proceedings · doi:10.1186/1753-6561-7-s6-p49 · Cited by 8
Cited by
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Huang, Y., Guo, X., Wu, Y., Chen, X., Feng, L., Xie, N., & Shen, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01745-z · Cited by 490
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential
Abdellatif, A. A., Younis, M. A., Alsharidah, M., Al Rugaie, O., & Tawfeek, H. M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s357980 · Cited by 284
Self-citation
Metadata
- Authors
- Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2022-02
- Volume
- 181
- Pages
- 114083
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4200229606
- Cited by
- 462
- References
- 106
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.